News

Whilst there are a number of risk factors, people who inject drugs bear the burden of Hepatitis C with 95% of new infections occurring within the injecting community. People who inject drugs make up a sizeable proportion of the 25,000 New Zealanders that we estimate are unaware that they may have hepatitis C.

Earlier this year a pan genotypic treatment, Mavriet became freely available and signaled a new era in Hepatitis C testing and treatment in New Zealand . “The funding of Mavriet and availability of this pan genotypic treatment is an absolute game changer and will make an enormous difference in the lives of many in our community”, says Kathryn Leafe, Executive Director. Learn More

Today marks the 6th International Harm Reduction Day, a day focussed on promoting evidence based public health policy, practices and human rights. Learn More

The New Zealand Needle Exchange Programme welcomes the government’s announcement this morning, and its long awaited response to our current public health crisis relating to synthetic drugs. Learn More

We welcome the release of the Mental Health and Addictions Inquiry’s Report this morning. The report is a comprehensive analysis of the current challenges within our mental health and addiction sector and we look forward to digesting the 219 page report in full. Learn More

At the New Zealand Needle Exchange Programme, we welcome the report released yesterday by Sense Partners and the New Zealand Drug Foundation. Learn More

Watch our Executive Director make this powerful statement on stigma to the CND. Learn More